Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7859)
All Articles published online
|
Publishing Process of This Article
|
Aug 16, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fabrizi F, Cresseri D, Fogazzi GB, Moroni G, Passerini P, Martin P, Messa P. Rituximab therapy for primary glomerulonephritis: Report on two cases. World J Clin Cases 2015; 3(8): 736-742 [PMID: 26301235 DOI: 10.12998/wjcc.v3.i8.736] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v3/i8/736.htm |
| Number | Citing Articles |
| 1 |
Fabrizio Fabrizi, Piergiorgio Messa. Glomerulonephritis. 2019; : 483 doi: 10.1007/978-3-319-49379-4_29
|
| 2 |
Francesco Scolari, Federico Alberici, Federica Mescia, Elisa Delbarba, Hernando Trujillo, Manuel Praga, Claudio Ponticelli. Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.789713
|
| 3 |
Fabrizio Fabrizi, Piergiorgio Messa. Glomerulonephritis. 2017; : 1 doi: 10.1007/978-3-319-27334-1_29-1
|
| 4 |
Fabrizio Fabrizi, Alessio Aghemo, Pietro Lampertico, Mirella Fraquelli, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesca M Donato, Piergiorgio Messa. Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up. The International Journal of Artificial Organs 2018; 41(6): 306 doi: 10.1177/0391398818762358
|
| 5 |
Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence. Pathogens 2019; 8(4): 176 doi: 10.3390/pathogens8040176
|
| 6 |
M.L.M. Lacerda, L.R.S. Scomparin, R.P. Andreussi, L.K.N. Guedes, M.R.U. Lopes, R.M.R. Pereira. USO DE RITUXIMABE NA CRIOGLOBULINEMIA ASSOCIADA A DOENÇAS REUMÁTICAS AUTOIMUNES. Revista Brasileira de Reumatologia 2017; 57: S303 doi: 10.1016/j.rbr.2017.07.403
|
| 7 |
Meghan E. Sise, Jessica Wisocky, Ivy A. Rosales, Donald Chute, Jacinta A. Holmes, Kristin M. Corapi, Jodie L. Babitt, Jessica S. Tangren, Nikroo Hashemi, Andrew L. Lundquist, Winfred W. Williams, David B. Mount, Karin L. Andersson, Helmut G. Rennke, R. Neal Smith, Robert Colvin, Ravi I. Thadhani, Raymond T. Chung. Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy. Kidney International Reports 2016; 1(3): 135 doi: 10.1016/j.ekir.2016.06.006
|
| 8 |
Fabrizio Fabrizi, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesco Pallotti, FrancescaMaria Donato, Pietro Lampertico, Piergiorgio Messa. Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease. Saudi Journal of Kidney Diseases and Transplantation 2020; 31(1): 109 doi: 10.4103/1319-2442.279930
|